NEW YORK (GenomeWeb News) – WaferGen Biosystems has received a €1 million ($1.3 million) matching grant from the Luxembourg government to expand its European operations, the company announced after the close of the market on Tuesday.
The first tranche of €350,000 is expected in the first quarter, the Fremont, Calif.-based company said, and will be used to offset startup and personnel costs. WaferGen is recruiting sales, support, and technical personnel and eventually will establish research and diagnostic capabilities in Luxembourg, where its European operation is headquartered.
In a statement, Ivan Trifunovich, president and CEO of WaferGen, said, "This grant will help us expand our European sales activities and enable us to provide regional support and service capabilities."
WaferGen first announced its plans to establish its European operations in Luxembourg in early 2010. Later that year, the company announced a collaboration with the Integrated BioBank of Luxembourg to co-develop molecular signatures for diagnostic research and commercial applications.